Airway mucus hypersecretion: Rationales for pharmacotherapy

References

• Del Donno M, Bittesnich D, Chetta A, Olivieri D, Lopez-Vidriero MT. The effect of inflammation on mucociliary clearance in asthma: an overview. Chest 2000; 118: 1142–9
   PubMed Web of Science ®Google Scholar
• Houtmeyers E, Gosselink R, Gayan-Ramirez G, Decramer M. Regulation of mucociliary clearance in health and disease. Eur Respir J 1999; 13: 1177–88
   PubMed Web of Science ®Google Scholar
• Maestrelli P, Saetta M, Mapp CE, Fabbri LM. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: S76–80
   PubMed Web of Science ®Google Scholar
• Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J 1995; 8: 1333–8
   PubMed Web of Science ®Google Scholar
• Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 2002; 109: 571–7
   PubMed Web of Science ®Google Scholar
• Davies JR, Herrmann A, Russell W, Svitacheva N, Wickström C, Carlstedt I. Respiratory tract mucins: structure and expression patterns. Mucus hypersecretion in respiratory disease, Novartis Foundation Symposium 248, DJ Chadwick, JA Goodem. John Wiley & Sons, ChichesterUK 2002; 76–88
   Google Scholar
• Rogers DF. The airway goblet cell. Int J Biochem Cell Biol 2003; 35: 1–6
   PubMed Web of Science ®Google Scholar
• Finkbeiner WE. Physiology and pathology of tracheobronchial glands. Respir Physiol 1999; 118: 77–83
   PubMedGoogle Scholar
• Moniaux N, Escande F, Porchet N, Aubert JP, Batra SK. Structural organization and classification of the human mucin genes. Front Biosci 2001; 6: D1192–206
   PubMed Web of Science ®Google Scholar
• Dekker J, Rossen JW, Buller HA, Einerhand AW. The MUC family: an obituary. Trends Biochem Sci 2002; 27: 126–31
   PubMed Web of Science ®Google Scholar
• Gum JR, Jr, Crawley SC, Hicks JW, Szymkowski DE, Kim YS. MUC17, a novel membrane-tethered mucin. Biochem Biophys Res Commun 2002; 291: 466–75
   PubMed Web of Science ®Google Scholar
• Wu GJ, Wu MW, Wang SW, Liu Z, Qu P, Peng Q, et al. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression. Gene 2001; 279: 17–31
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhao YH, Kalaslavadi TB, Hamati E, Nehrke K, Le AD, et al. Genome-wide search and identification of a novel gel-forming mucin MUC19/Muc19 in glandular tissues. Am J Respir Cell Mol Biol 2004; 30: 155–65
   PubMed Web of Science ®Google Scholar
• Higuchi T, Orita T, Nakanishi S, Katsuya K, Watanabe H, Yamasaki Y, et al. Molecular cloning, genomic structure, and expression analysis of MUC20, a novel mucin protein, up-regulated in injured kidney. J Biol Chem 2004; 279: 1968–79
   PubMed Web of Science ®Google Scholar
• Eapen SS, Busse WW. Asthma. Clin Allergy Immunol 2002; 16: 325–53
   Google Scholar
• Rogers DF. Airway mucus hypersecretion in asthma: an undervalued pathology?. Curr Opin Pharmacol 2004; 4: 241–50
   PubMed Web of Science ®Google Scholar
• Houston JC, De Navasquez S, Trounce JR. A clinical and pathological study of fatal cases of status asthmaticus. Thorax 1953; 8: 207–13
   PubMed Web of Science ®Google Scholar
• Dunnill MS. The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol 1960; 13: 27–33
   PubMed Web of Science ®Google Scholar
• Saetta M, Di Stefano A, Rosina C, Thiene G, Fabbri LM. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991; 143: 138–43
   PubMed Web of Science ®Google Scholar
• Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992; 101: 916–21
   PubMed Web of Science ®Google Scholar
• Ordonez CL, Khashayar R, Wong HH, Ferrando R, Wu R, Hyde DM, et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med 2001; 163: 517–23
   PubMed Web of Science ®Google Scholar
• Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. NIH Publication No. 2701. Bethesda, MD: National Heart, Lung and Blood Institute; 2001.
   Google Scholar
• Reid L. Pathology of chronic bronchitis. Lancet 1954; i: 275–8
   Google Scholar
• Aikawa T, Shimura S, Sasaki H, Takishima T, Yaegashi H, Takahashi T. Morphometric analysis of intraluminal mucus in airways in chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140: 477–82
   PubMed Web of Science ®Google Scholar
• Steiger D, Fahy J, Boushey H, Finkbeiner WE, Basbaum C. Use of mucin antibodies and cDNA probes to quantify hypersecretion in vivo in human airways. Am J Respir Cell Mol Biol 1994; 10: 538–45
   PubMed Web of Science ®Google Scholar
• Saetta M, Turato G, Baraldo S, Zanin A, Braccioni F, Mapp CE, et al. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med 2000; 161: 1016–21
   PubMed Web of Science ®Google Scholar
• Mullen JB, Wright JL, Wiggs BR, Pare PD, Hogg JC. Structure of central airways in current smokers and ex-smokers with and without mucus hypersecretion: relationship to lung function. Thorax 1987; 42: 843–8
   PubMed Web of Science ®Google Scholar
• Reid L. Measurement of the bronchial mucous gland layer: a diagnostic yardstick in chronic bronchitis. Thorax 1960; 15: 132–41
   PubMedGoogle Scholar
• Restrepo G. Heard BE. The size of the bronchial glands in chronic bronchitis. J Pathol Bacteriol 1963; 85: 305–10
   PubMedGoogle Scholar
• Jeffery PK. Differences and similarities between chronic obstructive pulmonary disease and asthma. Clin Exp Allergy 1999; 29(Suppl 2)14–26
   Google Scholar
• Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1304–9
   PubMed Web of Science ®Google Scholar
• Djukanovic R. Airway inflammation in asthma and its consequences: implications for treatment in children and adults. J Allergy Clin Immunol 2002; 109: S539–48
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004; 56: 515–48
   PubMed Web of Science ®Google Scholar
• Liu YC, Khawaja AM, Rogers DF. Pathophysiology of airway mucus secretion in asthma. Asthma. Basic mechanisms and clinical management3rd ed, PJ Barnes, IW Rodger, NC Thomson. Academic Press, London 1998; 205–27
   Google Scholar
• Lopez-Vidriero MT, Reid L. Chemical markers of mucous and serum glycoproteins and their relation to viscosity in mucoid and purulent sputum from various hypersecretory diseases. Am Rev Respir Dis 1978; 117: 465–77
   PubMed Web of Science ®Google Scholar
• Charman J, Reid L. Sputum viscosity in chronic bronchitis, bronchiectasis, asthma and cystic fibrosis. Biorheology 1972; 9: 185–99
   PubMedGoogle Scholar
• Shimura S, Sasaki T, Sasaki H, Takishima T, Umeya K. Viscoelastic properties of bronchorrhoea sputum in bronchial asthmatics. Biorheology 1988; 25: 173–9
   PubMed Web of Science ®Google Scholar
• Sheehan JK, Richardson PS, Fung DC, Howard M, Thornton DJ. Analysis of respiratory mucus glycoproteins in asthma: a detailed study from a patient who died in status asthmaticus. Am J Respir Cell Mol Biol 1995; 13: 748–56
   PubMed Web of Science ®Google Scholar
• Rogers DF, Evans TW. Plasma exudation and oedema in asthma. Br Med Bull 1992; 48: 120–34
   PubMed Web of Science ®Google Scholar
• Shimura S, Andoh Y, Haraguchi M, Shirato K. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J 1996; 9: 1395–401
   PubMed Web of Science ®Google Scholar
• Thornton DJ, Carlstedt I, Howard M, Devine PL, Price MR, Sheehan JK. Respiratory mucins: identification of core proteins and glycoforms. Biochem J 1996; 316: 967–75
   PubMed Web of Science ®Google Scholar
• Hovenberg HW, Davies JR, Herrmann A, Linden CJ, Carlstedt I. MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj J 1996; 13: 839–47
   PubMed Web of Science ®Google Scholar
• Wickstrom C, Davies JR, Eriksen GV, Veerman EC, Carlstedt I. MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage. Biochem J 1998; 334: 685–93
   PubMed Web of Science ®Google Scholar
• Sheehan JK, Howard M, Richardson PS, Longwill T, Thornton DJ. Physical characterization of a low-charge glycoform of the MUC5B mucin comprising the gel-phase of an asthmatic respiratory mucous plug. Biochem J 1999; 338: 507–13
   PubMed Web of Science ®Google Scholar
• Kirkham S, Sheehan JK, Knight D, Richardson PS, Thornton DJ. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem J 2002; 361: 537–46
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhao YH, Di YP, Wu R. Characterization of human mucin 5B gene expression in airway epithelium and the genomic clone of the amino-terminal and 5′-flanking region. Am J Respir Cell Mol Biol 2001; 25: 542–53
   PubMed Web of Science ®Google Scholar
• Davies JR, Carlstedt I. Respiratory tract mucins. Cilia and mucus: from development to respiratory defense, M Salthe. Marcel Dekker, Inc, New York 2001; 167–78
   Google Scholar
• Davies JR, Svitacheva N, Lannefors L, Kornfalt R, Carlstedt I. Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions. Biochem J 1999; 344: 321–30
   PubMed Web of Science ®Google Scholar
• Glynn AA, Michaels L. Bronchial biopsy in chronic bronchitis and asthma. Thorax 1960; 15: 142–53
   Google Scholar
• Houtmeyers E, Gosselink R, Gayan-Ramirez G, Decramer M. Effects of drugs on mucus clearance. Eur Respir J 1999; 14: 452–67
   PubMed Web of Science ®Google Scholar
• Rogers DF. Mucociliary dysfunction in COPD: effect of current pharmacotherapeutic options. Pulm Pharmacol Ther 2005; 18: 1–8
   PubMed Web of Science ®Google Scholar
• Rogers DF. The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options. COPD: J Chron Obstructive Dis 2006; 3: 341–353
   Google Scholar
• Rogers DF. Mucoactive drugs for asthma and COPD: any place in therapy?. Expert Opin Investig Drugs 2002; 11: 15–35
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax1 2004; 59(Suppl 1): 1–232
   Google Scholar
• Li Y, Martin LD, Spizz G, Adler KB. MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro. J Biol Chem 2001; 276: 40982–90
   PubMed Web of Science ®Google Scholar
• Singer M, Martin LD, Vargaftig BB, Park J, Gruber AD, Li Y, et al. A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma. Nat Med 2004; 10: 193–6
   PubMed Web of Science ®Google Scholar
• Evans C, Kheradmand F, Corry D, Tuvim M, Densmore C, Waldrep C, et al. Gene therapy of mucus hypersecretion in experimental asthma. Chest 2002; 121: 90S–1S
   PubMed Web of Science ®Google Scholar
• Foster KA. A new wrinkle on pain relief: re-engineering clostridial neurotoxins for analgesics. Drug Discov Today 2005; 10: 563–9
   Web of Science ®Google Scholar
• Ford E, Cruttwell C, Nute E, Chaddock J, Barnes P, Sutton J, et al. Inhibition of mucin secretion from A549 cells using a re-targeted clostridial endopeptidase [abstract]. Proc Am Thorac Soc 2005; 2: A219
   Google Scholar
• Burgel PR, Nadel JA. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 2004; 59: 992–6
   PubMed Web of Science ®Google Scholar
• O'Donnell RA, Richter A, Ward J, Angco G, Mehta A, Rousseau K, et al. Expression of ErbB receptors and mucins in the airways of long term current smokers. Thorax 2004; 59: 1032–40
   PubMed Web of Science ®Google Scholar
• Longphre M, Li D, Li J, Matovinovic E, Gallup M, Samet JM, et al. Lung mucin production is stimulated by the air pollutant residual oil fly ash. Toxicol Appl Pharmacol 2000; 162: 86–92
   PubMed Web of Science ®Google Scholar
• Shim JJ, Dabbagh K, Takeyama K, Burgel PR, Dao-Pick TP, Ueki IF, et al. Suplatast tosilate inhibits goblet-cell metaplasia of airway epithelium in sensitized mice. J Allergy Clin Immunol 2000; 105: 739–45
   PubMed Web of Science ®Google Scholar
• Wang B, Lim DJ, Han J, Kim YS, Basbaum CB, Li JD. Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphoinositide 3-kinase-Akt pathway. J Biol Chem 2002; 277: 949–57
   PubMed Web of Science ®Google Scholar
• Atherton HC, Jones G, Danahay H. IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation. Am J Physiol Lung Cell Mol Physiol 2003; 285: L730–9
   PubMed Web of Science ®Google Scholar
• Zhou Y, Shapiro M, Dong Q, Louahed J, Weiss C, Wan S, et al. A calcium-activated chloride channel blocker inhibits goblet cell metaplasia and mucus overproduction. Mucus hypersecretion in respiratory disease. Chichester. Wiley, UK 2002; 150–65
   Google Scholar
• Nakanishi A, Morita S, Iwashita H, Sagiya Y, Ashida Y, Shirafuji H, et al. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci U S A 2001; 98: 5175–80
   PubMed Web of Science ®Google Scholar
• Knight D. Talniflumate (Genaera). Curr Opin Invest Drugs 2004; 5: 557–62
   PubMedGoogle Scholar
• Guzman K, Gray TE, Yoon JH, Nettesheim P. Quantitation of mucin RNA by PCR reveals induction of both MUC2 and MUC5AC mRNA levels by retinoids. Am J Physiol 1996; 271: L1023–8
   PubMed Web of Science ®Google Scholar
• Yoon JH, Gray T, Guzman K, Koo JS, Nettesheim P. Regulation of the secretory phenotype of human airway epithelium by retinoic acid, triiodothyronine, and extracellular matrix. Am J Respir Cell Mol Biol 1997; 16: 724–31
   PubMed Web of Science ®Google Scholar
• Koo JS, Jetten AM, Belloni P, Yoon JH, Kim YD, Nettesheim P. Role of retinoid receptors in the regulation of mucin gene expression by retinoic acid in human tracheobronchial epithelial cells. Biochem J 1999; 338: 351–7
   PubMed Web of Science ®Google Scholar
• Apfel C, Bauer F, Crettaz M, Forni L, Kamber M, Kaufmann F, et al. A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci U S A 1992; 89: 7129–33
   PubMed Web of Science ®Google Scholar
• Bhattacharyya SN, Manna B, Smiley R, Ashbaugh P, Coutinho R, Kaufman B. Smoke-induced inhalation injury: effects of retinoic acid and antisense oligodeoxynucleotide on stability and differentiated state of the mucociliary epithelium. Inflammation 1998; 22: 203–14
   PubMed Web of Science ®Google Scholar
• Tesfaigzi Y, Fischer MJ, Martin AJ, Seagrave J. Bcl-2 in LPS- and allergen-induced hyperplastic mucous cells in airway epithelia of Brown Norway rats. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1210–7
   PubMed Web of Science ®Google Scholar
• Kellerman DJ. P2Y[2] receptor agonists: a new class of medication targeted at improved mucociliary clearance. Chest ;:S 2002; 121: 201S–5
   Google Scholar
• Roger P, Gascard JP, Bara J, de Montpreville VT, Yeadon M, Brink C. ATP induced MUC5AC release from human airways in vitro. Mediators Inflamm 2000; 9: 277–84
   PubMed Web of Science ®Google Scholar
• Jackson AD. Airway goblet-cell mucus secretion. Trends Pharmacol Sci 2001; 22: 39–45
   PubMed Web of Science ®Google Scholar
• Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 2002; 109: 571–7
   PubMed Web of Science ®Google Scholar